1707 — Grape King Bio Balance Sheet
0.000.00%
- TWD20.22bn
- TWD17.68bn
- TWD11.16bn
- 96
- 62
- 82
- 94
Annual balance sheet for Grape King Bio, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 3,005 | 3,897 | 4,790 | 4,970 | 4,432 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 205 | 314 | 284 | 315 | 336 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3,971 | 4,985 | 5,801 | 6,039 | 5,596 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 7,532 | 7,483 | 7,650 | 7,795 | 7,949 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 13,104 | 14,061 | 15,053 | 15,512 | 15,324 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3,501 | 3,294 | 3,712 | 3,647 | 3,323 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 6,480 | 5,073 | 5,483 | 5,534 | 5,268 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 6,624 | 8,988 | 9,570 | 9,978 | 10,056 |
Total Liabilities & Shareholders' Equity | 13,104 | 14,061 | 15,053 | 15,512 | 15,324 |
Total Common Shares Outstanding |